This synergistic interaction enhances overall insulinotropic and glucoregulatory efficacy, positioning tirzepatide as a first-in-class dual incretin receptor agonist with superior metabolic outcomes
Loading Comments Join today to unlock all member benefits including full access to all CL Answers and over 1,400 product reviews
Amgen Inc
Adam Gilden, MD, MSCE Medical Reviewer Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Me
Understanding GLP-1 pharmacokinetics and why timing matters To understand why you can take a GLP-1 injection early but not too early, you need to understand how these medications move through your body
Microbial Ecology, 75 (1), 228-238